Literature DB >> 26427661

Synthetic Tet-inducible small hairpin RNAs targeting hTERT or Bcl-2 inhibit malignant phenotypes of bladder cancer T24 and 5637 cells.

Junhao Lin1,2, Yuchen Liu3, Yonghao Zhan3,4, Chengle Zhuang3,4, Li Liu3,4, Xing Fu3, Wen Xu3,5, Jianfa Li3,4, Mingwei Chen3, Zhiming Cai6,7, Weiren Huang8,9.   

Abstract

Small hairpin RNA (shRNA) can inhibit the malignant phenotypes of tumor cell through ribonucleic acid interference (RNAi). However, it is hardly to be regulated and it may induce few phenotypic changes. Here, we build a type of tetracycline (Tet)-inducible vectors which can achieve regulatable expression of shRNA in a time-dependent manner by using synthetic biology approach. In order to prove the effectiveness of this device, we chose hTERT and Bcl-2 as target genes and test the utility of the device on 5637 and T24 cell lines. The experiments show that the Tet-inducible small hairpin RNA can effectively suppress their target genes and generate anti-cancer effects on both 5637 and T24 cell lines. The device we build not only can inhibit proliferation but also can induce apoptosis and suppress migration of the bladder cancer cell lines 5637 and T24. The Tet-inducible small hairpin RNAs may provide a novel strategy for the treatment of human bladder cancer in the future.

Entities:  

Keywords:  Bladder cancer; Tet-inducible shRNA; hTERT;Bcl-2

Mesh:

Substances:

Year:  2015        PMID: 26427661     DOI: 10.1007/s13277-015-4122-7

Source DB:  PubMed          Journal:  Tumour Biol        ISSN: 1010-4283


  21 in total

1.  Using siRNA technique to generate transgenic animals with spatiotemporal and conditional gene knockdown.

Authors:  Hung-Shu Chang; Ching-Hui Lin; Yu-Chi Chen; Winston C Y Yu
Journal:  Am J Pathol       Date:  2004-11       Impact factor: 4.307

Review 2.  The role of radiotherapy in urinary bladder cancer: current status.

Authors:  Gustavo Nader Marta; Samir Abdallah Hanna; Rafael Gadia; Sebastiao Francisco Miranda Correa; Joao Luis Fernandes da Silva; Heloisa de Andrade Carvalho
Journal:  Int Braz J Urol       Date:  2012 Mar-Apr       Impact factor: 1.541

Review 3.  Synthetic biology moving into the clinic.

Authors:  Warren C Ruder; Ting Lu; James J Collins
Journal:  Science       Date:  2011-09-02       Impact factor: 47.728

Review 4.  A renaissance in RNA synthetic biology: new mechanisms, applications and tools for the future.

Authors:  James Chappell; Kyle E Watters; Melissa K Takahashi; Julius B Lucks
Journal:  Curr Opin Chem Biol       Date:  2015-06-18       Impact factor: 8.822

Review 5.  Synthetic biology advancing clinical applications.

Authors:  Marc Folcher; Martin Fussenegger
Journal:  Curr Opin Chem Biol       Date:  2012-07-21       Impact factor: 8.822

6.  Interactive learning and action: realizing the promise of synthetic biology for global health.

Authors:  A Wieke Betten; Anneloes Roelofsen; Jacqueline E W Broerse
Journal:  Syst Synth Biol       Date:  2013-07-27

7.  RNA interference by expression of short-interfering RNAs and hairpin RNAs in mammalian cells.

Authors:  Jenn-Yah Yu; Stacy L DeRuiter; David L Turner
Journal:  Proc Natl Acad Sci U S A       Date:  2002-04-23       Impact factor: 11.205

8.  Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.

Authors:  Nikolaos E Stavropoulos; Ioannis Filiadis; Elli Ioachim; Konstantinos Hastazeris; Ioannis Tsimaris; Demetrios Kalogeras; Stella Stefanaki; Nicki J Agnantis
Journal:  Anticancer Res       Date:  2002 Nov-Dec       Impact factor: 2.480

9.  Reversible gene knockdown in mice using a tight, inducible shRNA expression system.

Authors:  Jost Seibler; Andre Kleinridders; Birgit Küter-Luks; Sandra Niehaves; Jens C Brüning; Frieder Schwenk
Journal:  Nucleic Acids Res       Date:  2007-03-21       Impact factor: 16.971

Review 10.  Synthetic biology for therapeutic applications.

Authors:  Zhanar Abil; Xiong Xiong; Huimin Zhao
Journal:  Mol Pharm       Date:  2014-08-13       Impact factor: 4.939

View more
  5 in total

1.  Increased expression of ZEB1-AS1 correlates with higher histopathological grade and promotes tumorigenesis in bladder cancer.

Authors:  Junhao Lin; Yonghao Zhan; Yuchen Liu; Zhicong Chen; Jianbo Liang; Wei Li; Anbang He; Liqun Zhou; Hongbin Mei; Feng Wang; Weiren Huang
Journal:  Oncotarget       Date:  2017-04-11

2.  Photoactivatable RNAi for cancer gene therapy triggered by near-infrared-irradiated single-walled carbon nanotubes.

Authors:  Xueling Ren; Jing Lin; Xuefang Wang; Xiao Liu; Erjuan Meng; Rui Zhang; Yanxiao Sang; Zhenzhong Zhang
Journal:  Int J Nanomedicine       Date:  2017-10-26

Review 3.  Recent development on synthetic biological devices treating bladder cancer.

Authors:  Zhicong Chen; Anbang He; Yuchen Liu; Weiren Huang; Zhiming Cai
Journal:  Synth Syst Biotechnol       Date:  2016-09-14

4.  Up-regulation of long non-coding RNA PANDAR is associated with poor prognosis and promotes tumorigenesis in bladder cancer.

Authors:  Yonghao Zhan; Junhao Lin; Yuchen Liu; Mingwei Chen; Xiaoying Chen; Chengle Zhuang; Li Liu; Wen Xu; Zhicong Chen; Anbang He; Qiaoxia Zhang; Xiaojuan Sun; Guoping Zhao; Weiren Huang
Journal:  J Exp Clin Cancer Res       Date:  2016-05-20

5.  Increased expression of SUMO1P3 predicts poor prognosis and promotes tumor growth and metastasis in bladder cancer.

Authors:  Yonghao Zhan; Yuchen Liu; Chaoliang Wang; Junhao Lin; Mingwei Chen; Xiaoying Chen; Chengle Zhuang; Li Liu; Wen Xu; Qing Zhou; Xiaojuan Sun; Qiaoxia Zhang; Guoping Zhao; Weiren Huang
Journal:  Oncotarget       Date:  2016-03-29
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.